Fsd Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc. has resolved a debt of $637,650 by issuing 545,000 Class B Subordinate Voting shares, while also granting 55,000 restricted share units to consultants under its equity incentive plan. The biopharmaceutical company is engaged in the development of treatments for neurodegenerative and metabolic disorders, along with alcohol misuse, and continues to make strategic investments in property-secured loans.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
